ENP project 2015
ENP project activities in 2015
The EMCDDA project targets 7 European Neighbourhood Policy (ENP) partner countries. These are: Armenia, Azerbaijan, Georgia, Israel, Moldova, Morocco and Ukraine.
Timetable: January 2014–June 2016
Objective: The overall objective of the EMCDDA-ENPI project is to strengthen the capacity of ENP Partner countries to react to new challenges and developments of the drugs situation.
In order to achieve this, the project has defined a set of measurable and specific objectives:
- to support the partner countries to produce new information on their drugs situation;
- to develop the capacity for monitoring;
- to strengthen the reporting and dissemination of information.
Expected results are:
- a better knowledge of recent and emerging trends in drug use in the partner ENP countries among young people;
- the Early Warning System covers the new ENP partner countries for its ALERT component, which makes it more comprehensive and more accurate and enables effective exchange of information between EU member states and ENP countries;
- increased capacity for data collection, analysis and interpretation in the ENP countries, as a result of the knowledge transfer facilitated by the project;
- decision-makers at national and EU level are better informed on the drugs situation and on the need for interventions;ENP partners and other Reitox members have a better knowledge and understanding of the drugs situation and of the role of drug monitoring.
- RTX Academy on monitoring and control of new psychoactive substances
- EMCDDA technical visit to Yerevan, Republic of Armenia
- Study visit of Moldovan delegation to Romanian national focal point
- Early Warning System annual expert meeting
- Signing ceremony of the Memorandum of Understanding (MoU) with Armenia
- Drug-related infectious diseases (DRID) annual expert meeting
- Visit of a Ukrainian delegation to the EMCDDA
- Legal and policy correspondents meeting
- 20 years of monitoring with key indicators
- Lisbon Addictions Conference
- Signing ceremony of the Memorandum of Understanding (MoU) with Georgia
- RTX Academy on Treatment Demand Indicator
- 4th extended Reitox week
- Reitox Academy on best practice in drug use prevention
- The European School Survey Project on Alcohol and other drugs (ESPAD)
Reitox Academy on monitoring and control of new psychoactive substances, Tbilisi, Georgia, 16–17 April
This Academy was planned following a request made by representatives of European Neighbourhood Policy (ENP) countries to organise a special training session on challenges related to the monitoring and control of emerging threats in relation to new psychoactive substances (NPS). It was organised in the framework of the project ‘Towards a gradual improvement of ENP partner countries’ capacity to monitor and to meet drug-related challenges’ funded by the European Commission, and in cooperation with the Ministry of Justice of Georgia.
The specific objectives of the Academy were to increase the participants’ awareness on the European Early Warning System (EWS), with the ultimate goal of initiating a partnership on the exchange of information on NPS, and to share experiences on legal practices for the control of NPS among experts from the European Union (EU) Member States and ENP countries.
The Reitox Academy brought together 27 participants, representing national monitoring bodies, national law enforcement agencies (Ministry of Interior and police, customs, Ministry of Justice), and national forensic laboratories from Azerbaijan (2 persons), Belarus (2 persons), Georgia (17 persons), Israel (3 persons), Moldova (3 persons) and Ukraine (2 persons).
EMCDDA technical visit to Yerevan, Republic of Armenia , 27–30 April
As part of the EMCDDA–ENP Project, an EMCDDA delegation was invited to a technical visit to the Republic of Armenia. The main objective of this visit was to meet with the representatives of the drug data collection entities within the Ministry of Health, the Ministry of the Interior and the National Security Council, and to identify their current needs and working methods in this field. These meetings also contributed to further developing cooperation between the Republic of Armenia and the EMCDDA and to preparing a more detailed work plan for future common activities.
Study visit of Moldovan delegation to Romanian national focal point, Bucharest, Romania, 25–27 May
Four experts from Moldova visited the Romanian national focal point to share experiences in monitoring the treatment demand indicator, information on drug-related infectious diseases and monitoring of drug-related deaths. All together they drafted updates for a country situation summary on Moldova, based on the EMCDDA’s guidelines and a review of the most recent Moldovan national report on drugs.
Early Warning System annual expert meeting, EMCDDA, Lisbon, 8–9 June
The EU Early Warning System works by collecting information on the appearance of new substances from the 28 Member States, Turkey and Norway and then monitoring them, thus allowing the EU to respond rapidly to emerging threats. The specific objectives of this annual meeting were to discuss the recent developments concerning NPS at national level, in particular those related to the market, legal changes, national EWS and risk assessment systems; to identify emerging concerns at national and European level with a focus on specific substances; to review and discuss developments towards strengthening the toxicovigilance system; and to discuss how we can strengthen public health alerts, including the scope of dissemination, risk communication etc.
The costs for the participation of a representative of Israel in this meeting was supported by the ENP1 project ‘Towards a gradual improvement of ENP partner countries’ capacity to monitor and to meet drug-related challenges’, funded by the European Commission.
Signing ceremony of the Memorandum of Understanding (MoU), Yerevan, Armenia, 13–16 June
The MoU between the National Security Council of the Republic of Armenia and the EMCDDA is guided by the principles and aims of an existing multilateral international agreement on drug control. Both parties expressed their wish to develop a framework of mutual cooperation in the field of information on preventing and responding to illicit drug use, in line with international standards; and to share experiences and knowledge of methodologies aiming to develop and harmonise indicators of the drug situation and to develop an information system.
Drug-related infectious diseases (DRID) annual expert meeting, EMCDDA, Lisbon, 15–16 June
This year’s DRID key epidemiological indicator meeting focused on the most recent trends and briefings by national experts, such as updating the regional assessment of HIV risks and responses; hepatitis C infections and treatment; botulism and other infections; emerging risks related to the injection of stimulants, including new psychoactive substances; and drug-related health issues among prison populations. It included two sets of parallel workshops and four ‘conference-like’ plenaries.
The ENP1 project ‘Towards a gradual improvement of ENP partner countries’ capacity to monitor and to meet drug-related challenges’ funded by the European Commission, financed the participation of a representative from Israel and Moldova, respectively, at this meeting.
Visit of a Ukrainian delegation to the EMCDDA, Lisbon, 22 July
A Ukrainian delegation composed of the First Deputy Health Minister of Ukraine, two members of the Ukrainian Monitoring and Medical Centre for drugs and alcohol, and a representative of the Embassy of Ukraine in Portugal, visited the EMCDDA on 22 July 2015.
The purpose of the meeting was exchange information about the adoption, since March 2015, of a new plan of action for the implementation of the National Drug Strategy until 2020 by the Ukrainian government. As a country included in the ENP project, the perspectives for further cooperation with the EMCDDA and the organisation of targeted training sessions in Ukraine on topics to be proposed by the host country were highly praised.
Legal and policy correspondents meeting, EMCDDA, 8–9 September
The agenda of this meeting is organised around four main sessions that map its main objectives of reviewing recent developments concerning legislation controlling drugs and new psychoactive substances at national level; exchanging and discussing information on specific topics that have been identified last year by legal correspondents or EMCDDA as of particular interest; reviewing and discussing developments in legislation prioritised by the 2013–2016 EU Action Plan on Drugs; and to reinforce the role of the network as a multilateral resource, not only linked to the European Legal Database on Drugs but also able to provide assistance to any national expert as the need may arise.
Participation of one national expert from the Republic of Armenia, Israel and Ukraine, respectively, at this meeting was supported by the project ‘Towards a gradual improvement of ENP partner countries’ capacity to monitor and to meet drug-related challenges’, funded by the European Commission.
20 years of monitoring with key indicators, EMCDDA, Lisbon, 21–22 September
Building on national efforts and formative European level activities, the EMCDDA has for the last 20 years been working to improve the monitoring of the European drug situation. A core element of this work, and an explicit priority of the Centre, has been the development of a set of key epidemiological indicators (KI) supported by expert technical working groups. Work to develop these indicators has been conducted in close cooperation with the Reitox national focal points, and a considerable share of the KI added-value remains at national level.
This special conference of the KI expert network therefore provided a much-needed opportunity to bring together experts from all the KI working groups, EMCDDA staff members, representatives of national focal points and other experts working in key information domains. It allowed the sharing of perspectives from the different technical domains covered by the EMCDDA monitoring tasks and for experts to explore how different information sources can be brought together not only to understand better the nature of the drugs problem but also to help inform the development and evaluation of effective interventions.
Within the framework of ENPI technical cooperation project ‘Towards a gradual improvement of ENP partner countries capacity to monitor and to meet drug-related challenges’ funded by the European Commission, participation of experts from Georgia, Morocco, Moldova, Israel and Ukraine, respectively, was supported.
Lisbon Addictions Conference, Lisbon, FIL meeting centre, Parque das Nações, 23–25 September
This major new event in the addictions calendar was organised by the Portuguese General-Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD — Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências) in collaboration with the EMCDDA.
There were opportunities for European and international top addiction experts to present new findings on illicit drugs, alcohol, tobacco, gambling and other addictive behaviours; there will be multi-disciplinary workshops and discussion forums covering epidemiology, policy research, clinical research, social sciences, behavioural science and human psychopharmacology.
Within the framework of ENPI technical cooperation project ‘Towards a gradual improvement of ENP partner countries’ capacity to monitor and to meet drug-related challenges’ funded by the European Commission, participation of drug-monitoring experts from Georgia, Morocco, Moldova and Israel, respectively, was supported.
Signing ceremony of the Memorandum of Understanding (MoU), Tbilisi, Georgia, 4 November
A Memorandum of Understanding between the European Monitoring Centre for Drugs and Drug Addiction and the Minister of Justice of Georgia was signed on 4 November 2015.
This accord — signed for an initial period of five years — will be implemented through a joint work programme to be updated every three years. The programme will include steps to enhance the partners’ monitoring and knowledge base on the drug situation and responses to it, particularly through harmonising key indicators in areas of supply and demand. Special attention will be given to the regular exchange of information on the emergence and use of new psychotropic substances, as well as the technologies employed in their production.
Reitox Academy on Treatment Demand Indicator , the challenge for monitoring and evaluation systems, Israel, Jerusalem, 11–12 November
This Reitox Academy is part of the project ’Towards a gradual improvement of European Neighbourhood Policy (ENP) partner countries’ capacity to monitor and to meet drug-related challenges’ and in close collaboration with the Israeli Anti-Drug Authority (IADA).
The main objectives of the Academy are a better understanding of the utilisation of the TDI indicator, including tools, processes and methods for data collection, analysis and reporting in the context of monitoring complex drug treatment systems; a better understanding of opportunities and limitations for use of TDI data for other research studies, identification of new trends and in studying treatment outcomes in particular; sharing best practices on the implementation of TDI in some European countries; and developing a roadmap to estimate drug-related public expenditure in Israel.
Around 30 national experts representing IADA, the Ministry of Health and the Ministry of Welfare, the National Insurance Institute of Israel, the main treatment facilities responsible for data collection and reporting on treatment, the police force, research institutes and academia will participate in the meeting.
Fourth Extended Reitox Week, EMCDDA, Lisbon, 23–24 November
The extended Reitox week will be divided into two parts: during the first two days, it will bring together national drug observatories and national correspondents from Candidate, Potential Candidate and Neighbouring countries, and from Russia, in order to exchange information on practical and thematic issues linked to monitoring the drugs situation at national and European level. The thematic thread of this year will be ’Women in treatment and interventions targeting young women’.
In the remaining days of the week, the event will also involve EU (plus Norway and Turkey) members of the Reitox network.
Reitox Academy on best practice in drug use prevention , Morocco 8–9 December
The objective of this Academy will be the dissemination of EU experience in monitoring and responding to drugs. For discussion will be topics regarding the main concepts of drug prevention and practices in the EU; updates on drug prevention activities and research in prevention; the role of standards in the framework of quality of interventions; and national and supra-national standards, among others. It is expected that around 25 national professionals will attend the Reitox Academy.
European School Survey Project on Alcohol and other drugs (ESPAD)
The European School Survey Project on Alcohol and Other Drugs is part of the activities foreseen in the EMCDDA-ENPI first technical cooperation project ‘Towards a gradual improvement of ENP partner countries’ capacity to monitor and to meet drug-related challenges’, funded by the European Commission.
The overall aim of this survey is to collect comparable data on substance use among 15-and 16-year-old students in as many countries as possible.
The project will support the implementation of ESPAD studies in Armenia, Georgia, Ukraine and Moldova in 2015.